Collectively, these observations support the notion that the miR-200 family of microRNAs influences the sensitivity of ovarian cancer cells to conventional chemotherapies through multiple mechanisms, including, but not limited to, interference with cellular microtubule assembly, regulating NF-κB signaling, and the EMT/MET processes. Here, NFKB1 is linked to ovarian carcinoma.